Literature DB >> 19806246

Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years.

Karen Koopman1, Maarten Uyttenboogaart, Patrick C A J Vroomen, Jan van der Meer, Jacques De Keyser, Gert-Jan Luijckx.   

Abstract

Cerebral venous thrombosis (CVT) and deep vein thrombosis or pulmonary embolism (DVT/PE) are associated with many risk factors. It is unclear why CVT occurs less often than DVT/PE. Age dependent risk factors may play a role. The aim of our study was to compare risk factors in a uniform age group of CVT and DVT/PE patients aged between 15 and 50 years. Thrombophilic markers and clinical risk factors of 79 CVT patients and 173 DVT/PE patients aged 15-50 years were compared. Multivariable logistic regression analysis was performed to investigate if risk factors were independently associated with CVT or DVT/PE. Cerebral venous thrombosis patients were younger (median age 30 years vs. 42 years; p<0.001) and more often female (82% vs. 52%; p<0.001). There were no differences in thrombophilic markers. Cerebral venous thrombosis was less often associated with trauma, immobilisation or surgery than DVT/PE (6% vs. 21%; adjusted OR 0.29; 95%CI 0.10-0.82). In women, CVT was more frequently associated with oral contraceptive use, pregnancy or puerperium (82% vs. 53%; adjusted OR 2.34; 95%CI 1.03-5.32). This study demonstrated no differences in thrombophilic markers between CVT patients and DVT/PE patients aged between 15 and 50 years, while the frequency of some transient risk factors was different. Cerebral venous thrombosis was relatively more common in women and hormonal factors may predispose to CVT compared to DVT/PE, while trauma, immobilisation and surgery may be less important in the pathophysiology of CVT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806246     DOI: 10.1160/TH09-06-0346

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Association of interleukin-18 gene polymorphism and its protein expression with the lower extremity deep venous thrombosis in the chinese han population: A case-control study.

Authors:  Ye-Long Chen; Li-Hong Shou; Zong-Xin Zhang
Journal:  J Clin Lab Anal       Date:  2017-11-04       Impact factor: 2.352

2.  Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation.

Authors:  Shuangli Zhu; ZhiGang Wang; XiaoPing Wu; Yan Shu; DunXiang Lu
Journal:  Lipids Health Dis       Date:  2014-01-24       Impact factor: 3.876

3.  Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol.

Authors:  Ioana Cotlarciuc; Thomas Marjot; Muhammad S Khan; Sini Hiltunen; Elena Haapaniemi; Tiina M Metso; Jukka Putaala; Susanna M Zuurbier; Matthijs C Brouwer; Serena M Passamonti; Paolo Bucciarelli; Emanuela Pappalardo; Tasmin Patel; Paolo Costa; Marina Colombi; Patrícia Canhão; Aleksander Tkach; Rosa Santacroce; Maurizio Margaglione; Giovanni Favuzzi; Elvira Grandone; Donatella Colaizzo; Kostas Spengos; Antonio Arauz; Amanda Hodge; Reina Ditta; Stephanie Debette; Marialuisa Zedde; Guillaume Pare; José M Ferro; Vincent Thijs; Alessandro Pezzini; Jennifer J Majersik; Ida Martinelli; Jonathan M Coutinho; Turgut Tatlisumak; Pankaj Sharma
Journal:  BMJ Open       Date:  2016-11-22       Impact factor: 2.692

4.  Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center.

Authors:  Virendra C Patil; Kushal Choraria; Neeraj Desai; Sumit Agrawal
Journal:  J Neurosci Rural Pract       Date:  2014-07

5.  Clinical features, risk factors, and outcome of cerebral venous thrombosis in Tehran, Iran.

Authors:  Samira Yadegari; Askar Ghorbani; S Roohollah Miri; Mohammad Abdollahi; Mohsen Rostami
Journal:  J Neurosci Rural Pract       Date:  2016 Oct-Dec

6.  A Rare Case of Cryptococcus gattii Meningitis in Advanced HIV Disease, Sagittal Thrombosis, and Immune Reconstitution Syndrome, Resolved With Isavuconazonium.

Authors:  Jerome Okudo; Valerie F Civelli; Vishal K Narang; Royce H Johnson; Nadir Khan; Brittany Andruszko; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.